Evidence map›Paper›PMID 31026391›Full record

ArticleCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology2019

Exosomes Treatment Mitigates Ischemic Brain Damage but Does Not Improve Post-Stroke Neurological Outcome.

Koteswara Rao Nalamolu, Ishwarya Venkatesh, Adithya Mohandass, Jeffrey D Klopfenstein, David M Pinson, David Z Wang, Krishna Kumar Veeravalli

Abstract read
In one paragraph

Article in Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pleiotropic Effects of Exosomes as a Therapy for Stroke Recovery.International journal of molecular sciences · 2020
    Pooled it
  5. Pooled it
  6. Review
  7. Article
  8. Review
  9. Secretome as a Tool to Treat Neurological Conditions: Are We Ready?International journal of molecular sciences · 2023
    Review
  10. Article
  11. Review
  12. Research progress of mesenchymal stem cell-derived exosomes on inflammatory response after ischemic stroke.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2022
    Review
  13. The Role of Stem Cells in the Therapy of Stroke.Current neuropharmacology · 2022
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Koteswara Rao NalamoluDepartment of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, USA.
Ishwarya VenkateshDepartment of Internal Medicine, Rush University Medical Center, Chicago, USA.
Adithya MohandassSchool of Pharmacy, College of Health Sciences, University of Wyoming, Laramie, USA.
Jeffrey D KlopfensteinDepartment of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, USA.
David M PinsonDepartment of Pathology, University of Illinois College of Medicine at Peoria, Peoria, USA.
David Z WangComprehensive Stroke Center, OSF Illinois Neurological Institute, Peoria, USA.
Krishna Kumar VeeravalliDepartment of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, USA.

Funding

MMP-12 and post-stroke brain damageR01NS102573 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI VEERAVALLI, KRISHNA KUMAR · 2018 to 2022
$1.8M
NIH HHS 1R01NS102573-01A1NINDS NIH HHS R01 NS102573OSF HealthCare Illinois Neurological InstituteWilliam E. McElroy Charitable Foundation
6 · The paper itself

Abstract

BACKGROUND/

aimsRecent studies demonstrated that the treatment with mesenchymal stem cells (MSCs) obtained from the human umbilical cord blood improved survival, reduced brain damage, prevented apoptosis, suppressed inflammatory responses, downregulated the DNA damage-inducing genes, upregulated the DNA repair genes, and facilitated neurological recovery in stroke-induced animals. Emerging stroke literature supports the concept that the exosomes released from MSCs are the primary biological principles underlying the post-stroke neuroprotection offered by MSCs treatment.

methodsBecause the treatment with exosomes has a great potential to overcome the limitations associated with cell-based therapies, we tested the efficacy of exosomes secreted from HUCB-MSCs under standard culture conditions on post-stroke brain damage and neurological outcome in a rat model of ischemic stroke by performing TTC staining as well as the modified neurological severity scores, modified adhesive removal, beam-walking, and accelerating Rotarod performance tests before ischemia and at regular intervals until seven days reperfusion.

resultsExosomes treatment attenuated the infarct size. Treatment with exosomes did not affect the post-stroke survival rate and body weight changes, but exacerbated the somatosensory and motor dysfunction and adversely affected the natural recovery that occurs without any treatment.

conclusionTreatment with exosomes secreted from HUCB-MSCs under standard culture conditions attenuates the ischemic brain damage but does not improve the post-stroke neurological outcome.

Indexed as

AnimalsBrainCell LineDisease Models, AnimalExosomesMaleMesenchymal Stem CellsMotor ActivityRats, Sprague-DawleyStrokeTreatment OutcomeExosomesIschemiaRecoveryReperfusionStem cellsStroke

Identifiers

PMID31026391
PMCPMC6996798

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.